For decades, the global pharmaceutical industry has spread a deceptive narrative justifying the ever-increasing, sky-high prices of drugs, vaccines and diagnostics as something necessary and inevitable.
MSF’s Access Campaign has repeatedly challenged this deadly narrative, calling for affordable access to lifesaving medicines, prioritisation of people’s health over profits, and transparency around the research and development (R&D) process.
Yet pharmaceutical corporations continue to perpetuate a series of myths about the development costs and pricing of medicines and other health products, in order to protect their profit-maximising practices – at the expense of people’s lives. One pharmaceutical financial investors’ report even went as far as to ask, “Is curing patients a sustainable business model?”
